Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarah Walker

Showing results (141-150 of 358) with videos related to

Pageof 36
Sort By:
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
The Journal of Infectious Diseases|November 13, 2013
Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficileDavid W Eyre, Farah Babakhani, David Griffiths, et al.
The Journal of Infection|December 29, 2021
Impact of antibiotic use on patient-level risk of death in 36 million hospital admissions in EnglandEric P Budgell, Timothy J Davies, Tjibbe Donker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
Pediatric underdosing of efavirenz: a pharmacokinetic study in UgandaQuirine Fillekes, Eva Natukunda, Jackie Balungi, et al.
BJGP Open|June 8, 2023
Impact of the COVID-19 pandemic on antimicrobial stewardship support for general practices in England: a qualitative interview studyAnne Campbell, Aleksandra J Borek, Monsey McLeod, et al.
Frontiers in Microbiology|February 25, 2017
Plasmid Classification in an Era of Whole-Genome Sequencing: Application in Studies of Antibiotic Resistance EpidemiologyAlex Orlek, Nicole Stoesser, Muna F Anjum, et al.
Pageof 36

Showing results (141-150 of 358) with videos related to

Sort By:
Pageof 36
Plos One|February 26, 2013
A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteriaCharles F Gilks, A Sarah Walker, Paula Munderi, et al.
The Journal of Antimicrobial Chemotherapy|July 19, 2013
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trialQuirine Fillekes, Eva P Muro, Catherine Chunda, et al.
AIDS (London, England)|June 29, 2012
Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tabletsQuirine Fillekes, Veronica Mulenga, Desiré Kabamba, et al.
AIDS (London, England)|February 1, 2023
Impact of sub-optimal HIV viral control on activated T cellsFrancesca I F Arrigoni, Moira Spyer, Patricia Hunter, et al.
The Journal of Antimicrobial Chemotherapy|October 7, 2016
Effect of diurnal variation, CYP2B6 genotype and age on the pharmacokinetics of nevirapine in African childrenAndrzej Bienczak, Adrian Cook, Lubbe Wiesner, et al.
The Journal of Infectious Diseases|November 13, 2013
Whole-genome sequencing demonstrates that fidaxomicin is superior to vancomycin for preventing reinfection and relapse of infection with Clostridium difficileDavid W Eyre, Farah Babakhani, David Griffiths, et al.
The Journal of Infection|December 29, 2021
Impact of antibiotic use on patient-level risk of death in 36 million hospital admissions in EnglandEric P Budgell, Timothy J Davies, Tjibbe Donker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 20, 2011
Pediatric underdosing of efavirenz: a pharmacokinetic study in UgandaQuirine Fillekes, Eva Natukunda, Jackie Balungi, et al.
BJGP Open|June 8, 2023
Impact of the COVID-19 pandemic on antimicrobial stewardship support for general practices in England: a qualitative interview studyAnne Campbell, Aleksandra J Borek, Monsey McLeod, et al.
Frontiers in Microbiology|February 25, 2017
Plasmid Classification in an Era of Whole-Genome Sequencing: Application in Studies of Antibiotic Resistance EpidemiologyAlex Orlek, Nicole Stoesser, Muna F Anjum, et al.
Pageof 36